Research ArticleCancer

The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma

See allHide authors and affiliations

Science Translational Medicine  29 Jul 2020:
Vol. 12, Issue 554, eaaz3339
DOI: 10.1126/scitranslmed.aaz3339

Article Information

vol. 12 no. 554

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication September 3, 2019
  • Accepted for publication June 2, 2020
  • .

Author Information

  1. Premal D. Lulla*,
  2. Ifigeneia Tzannou,
  3. Spyridoula Vasileiou,
  4. George Carrum,
  5. Carlos A. Ramos,
  6. Rammurti Kamble,
  7. Tao Wang,
  8. Mengfen Wu,
  9. Mrinalini Bilgi,
  10. Adrian P. Gee,
  11. Shivani Mukhi,
  12. Betty Chung,
  13. Linghua Wang,
  14. Ayumi Watanabe,
  15. Manik Kuvalekar,
  16. Mira Jeong,
  17. Yumei Li,
  18. Shamika Ketkar,
  19. Matthew French-Kim,
  20. Bambi Grilley,
  21. Malcolm K. Brenner,
  22. Helen E. Heslop,
  23. Juan F. Vera and
  24. Ann M. Leen
  1. Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, Houston, TX 77030, USA.
  1. *Corresponding author. Email: lulla{at}bcm.edu

Altmetric

Article usage

Article usage: July 2020 to August 2020

AbstractFullPdf
Jul 202020941134
Aug 20201132112415

Stay Connected to Science Translational Medicine

Navigate This Article